Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1, Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), porphyria, hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1

SCIENTIFIC RESEARCH, SCIENTIFIC RESEARCH IN THE FIELDS OF PHARMACEUTICALS AND MEDICINE, CHEMICAL AND MEDICAL LABORATORIES

DNA screening for scientific research purposes; DNA screening for forensic research purposes; DNA screening for genetic mutations for scientific research purposes; DNA screening for genetic mutations for forensic research purposes

Providing information on financial assistance programs for the access of pharmaceutical treatments and therapies; reimbursement payment processing services in the field of health care

Providing information on financial assistance programs; reimbursement payment processing services in the field of health care

DNA screening for scientific research purposes; DNA screening for forensic research purposes; DNA screening for genetic mutations for scientific research purposes; DNA screening for genetic mutations for forensic research purposes

a full line of pharmaceuticals, biosimilars and biological preparations for medical purposes

DNA screening for scientific research purposes; DNA screening for forensic research purposes; DNA screening for genetic mutations for scientific research purposes; DNA screening for genetic mutations for forensic research purposes